Share Facebook Twitter LinkedIn Pinterest Email Alnylam reports positive Phase 2 data for hypertension drug
FedEx raises FY ’26 EPS outlook to $19.30-$20.10 as profitable B2B growth and Network 2.0 drive margin gains (NYSE:FDX)March 20, 2026
GrowGeneration outlines 2026 breakeven EBITDA target and 40% proprietary brand sales amid cost discipline and share buyback (NASDAQ:GRWG)March 20, 2026
